A Historic Milestone for Brinter and Regenerative Implants

October 7, 2026 – Brinter, a medical device company developing multi-material 3D-bioprinted regenerative implants, today announced the successful implantation of the first fully 3D-bioprinted regenerative implant in a live large-animal model at Colorado State University.

The procedure was successfully completed on October 6, 2026, at Colorado State University, Institute for Translational Medicine. This represents a major milestone for Brinter and regenerative implants. The company believes the achievement marks an important step in the evolution of 3D bioprinting—from primarily research and development applications toward implantable, FDA-approved, regenerative medical devices designed to function inside the body.

The study will evaluate the performance, tissue integration, biocompatibility, and regenerative response of Brinter’s implant technology in a clinically relevant large-animal model. Initial data are expected in approximately six weeks.

“This is a historic moment for Brinter and an incredibly important milestone for our team. What began as an idea to use our multi-material 3D-bioprinting technology to manufacture regenerative implants is now being tested inside a living large-animal model,” said Tom Alapaattikoski, Co-Founder and CEO of Brinter.

Brinter’s technology combines proprietary multi-material 3D bioprinting platform with resorbable biomaterials to create regenerative implants designed to provide mechanical support while enabling tissue integration and the body’s natural healing processes. Brinter's initial research program is focused on rotator cuff repair, where failed healing and cost pressures remain major clinical challenges.

“We are incredibly proud of our team and grateful to our research partners who helped us reach this historic milestone,” said Theo Arhio, COO.

About Brinter

Brinter is a medical device company developing multi-material 3D-bioprinted regenerative implants for soft-tissue repair and reconstruction. Its technology combines proprietary 3D-bioprinting with advanced resorbable biomaterials to create implants designed to provide structural support, promote tissue integration, and enable regeneration.